OVERVIEW
ABOUT SOCIETY
EDITORIAL INFORMATION
SUBMIT A MANUSCRIPT
ABSTRACTING & INDEXING
SUPPLEMENTARY INFORMATION
ADVERTISEMENTS AND ANNOUNCEMENTS

OVERVIEW

AIMS & SCABB 2021 Annual Meeting: June 9-12 ,2021

As a highly respected journal with an international readership, Immunohematology, Journal of Blood Group Serology and Molecular Genetics is published quarterly (March, June, September, and December) by The American National Red Cross.The journal is subscription based and peer reviewed and brings together research and clinical practice from well-known experts in the field of blood group serology and molecular immunogenetics.

Aim and Scope

Immunohematology, Journal of Blood Group Serology and Molecular Genetics publishes case reports, original scientific reports, conference reports, book reviews, editorial commentaries, and review articles covering the spectrum of clinical and laboratory practice and research in the field of laboratory medicine. The journal welcomes manuscripts on red cell, white cell, and platelet serology as well as original scientific investigations of new blood group alleles, molecular testing platforms, and new methods for use in the blood bank. Immunohematlogy cases that illustrate a sound investigative approach with clinical correlation, reflecting appropriate collaboration to sharpen problem-solving skills can be submitted as an educational forum.

Open Access

One article per published issue is available in open access format for all readers. Identification of this article is noted in 'Recently published' section.

Peer Review Process

Manuscripts submitted for publication in Immunohematology, Journal of Blood Group Serology and Molecular Genetics are peer reviewed by selected experts in the medical and technical field of transfusion medicine and/or immunohematology. Each peer reviewer assesses the manuscript for the novelty of the information, the quality and completeness of the provided scientific and clinical data, the quality and appropriateness of the tables and figures, the overall clarity of presentation of the information, and the interest of this topic to the readers of this journal. In addition, each reviewer determines if additional statistical review is needed and if the references are current and appropriate.

Peer reviewers provide a final assessment to accept or reject the manuscript outright, or revise the manuscript. If revision is determined, the peer reviewer provides specific comments to improve the quality of the manuscript. The reviewers’ comments are compiled and reviewed by the overseeing editor who provides additional comments, if appropriate. All comments are then sent to the authors for reply and revision, if applicable.

The authors’ reply and revised manuscript are reviewed by the overseeing editor and acceptance/rejection of the manuscript is determined.

Confidentiality of all peer reviewers is respected.

Rejection rate: 25%

Subscription Rates

Annual Subscription Rates for 2021:

Individual Online Only: $75
Individual US Online and Print: $150
Individual Non-US Online and Print: $200
SBB Student Online Only: $0 Gratis with validation of SBB program enrollment
Institution Online Only: $350
Institution US Online and Print: $600
Institution Non-US Online and Print: $800

ABOUT SOCIETY

With a focus on better patient outcomes through shared expertise and designed for physicians and laboratory professionals in the areas of blood banking and transfusion medicine, SUCCESS® is a comprehensive suite of educational resources comprised of online instruction, industry publications, and learning events. In support of SUCCESS®, the American National Red Cross publishes Immunohematology, Journal of Blood Group Serology and Molecular Genetics on a quarterly basis with a focus on original research, invited reviews, case reports, and new allele publications.

EDITORIAL INFORMATION

Editor-in-Chief

Sandra Nance - National Laboratories, Biomedical Services, American Red Cross; University of Pennsylvania, Pennsylvania, United States

Editors

P. Dayand Borge Jr. - Biomedical Services, American Red Cross, Pennsylvania, United States
Corinne Goldberg - Biomedical Services, American Red Cross, North Carolina, United States
Margaret A. Keller - Molecular Laboratory, Biomedical Services, Pennsylvania, American Red Cross, United States
David Moolten - Biomedical Services, American Red Cross, Pennsylvania, United States

Managing Editor

Cynthia Flickinger - Biomedical Services, American Red Cross, Pennsylvania United States

Editorial Board

Barbara J. Bryant - University of Texas Medical Branch, Texas, United States
Lilian M. Castilho - Hemocentro Campinas, Unicamp, Brazil
Anne F. Eder - Georgetown University School of Medicine, Washington DC, United States
Melissa R. George - Penn State Milton S. Hershey Medical Center, Pennsylvania, United States
Julie Katz Karp - Thomas Jefferson University Hospital, Pennsylvania, United States
Jose Lima - University of Alabama, Alabama, United States
Christine Lomas-Francis - New York Blood Center, New York, United States
Geralyn M. Meny - Grifols Diagnostics Solutions, Inc., Texas, United States
Paul M. Ness - Johns Hopkins Hospital, Maryland, United States
Thierry Peyrard - National Institute of Blood Transfusion, Paris, France
Ira A. Shulman - LAC + USC Medical Center, California, United States
Jill R. Storry - Office of Medical Services; Lund University, Lund, Sweden
Nicole Thornton - NHS Blood and Transplant, Bristol, United Kingdom

Technical Editors

Janis R. Hamilton - Biomedical Services, American Red Cross, Michigan, United States
Christine Lomas-Francis - New York Blood Center, New York, United States
Dawn Rumsey - Rumsey Immunohematology Consulting, Duluth, Georgia, United States
Tiffany Walters - Biomedical Services, American Red Cross, North Carolina, United States